Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07096999
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Sponsor: University of Michigan Rogel Cancer Center
View on ClinicalTrials.gov
Summary
This study is being performed to establish the association between absorbed dose to tumor and response and absorbed dose to normal organs and toxicity following Lu177-PSMA radioligand therapy
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2025-01-23
Completion Date
2031-01-23
Last Updated
2025-07-31
Healthy Volunteers
No
Interventions
OTHER
Non-Interventional Study
Non-interventional study
Locations (1)
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States